Serum LDH Levels as a Prognostic Factor in Hodgkin's Disease
Author Information
Author(s): R. Garcia, J.M. Hernandez, M.D. Caballero, M. Gonzalez, J. Galende, M.C. del Cainizo, L. Vazquez, J.F. San Miguel
Primary Institution: Hospital Universitario, Universidad de Salamanca, Salamanca, Spain
Hypothesis
What is the prognostic influence of serum lactate dehydrogenase levels and other clinical factors in Hodgkin's disease?
Conclusion
The study concludes that elevated serum LDH levels are one of the most important prognostic factors in Hodgkin's disease.
Supporting Evidence
- LDH levels above 320 U/ml were significantly associated with lower rates of complete remission.
- Age above 45 years was also a significant factor affecting prognosis.
- Advanced clinical stages of Hodgkin's disease were linked to poorer outcomes.
Takeaway
Doctors can use blood tests to check LDH levels to help predict how well someone with Hodgkin's disease might do.
Methodology
The study analyzed clinico-biological characteristics of 137 patients diagnosed with Hodgkin's disease, using univariate and multivariate analyses to assess prognostic factors.
Limitations
The study was conducted in a single institution and may not be generalizable to all populations.
Participant Demographics
Median age was 38 years, with a slight predominance of males (55%).
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website